SOPHiA GENETICS wins Tech Tour Growth Award

Please login or
register
29.03.2019
Jurgi Camblong

Tech Tour announced its 2019 Growth Award winner on March 28 at the Tech Tour Growth Summit & Awards held in Lausanne. These were chosen from the 2019 Tech Tour Growth 50 companies, a group of Europe’s most promising super-scale up companies including ten start-ups from Switzerland, which in turn were selected from a long list of 312 companies.

The selection committee, chaired by Falk Müller-Veerse, Partner, Bryan Garnier & Co, and made up of 21 international venture capital and growth equity fund managers, chose the Award winner taking into account its achievement, impact and momentum.

SOPHiA GENETICS, the Swiss-based global leader in Data-Driven Medicine, took the Growth Award, joining past Award winners including, Darktrace, Devialet, Klarna and MySql. The selection committee were particularly impressed with SOPHiA GENETICS’ rapid growth, winning trust from clinicians across the globe leading them to serve over 920 hospitals in 77 countries.

Commenting on the win, Jurgi Camblong, CEO and co-founder of SOPHiA GENETICS said “We are honored to receive the Tech Tour Growth Award, which is a direct recognition and example of the rapid growth and global impact of SOPHiA GENETICS worldwide. The company thus achieves its mission of contributing to a more sustainable global healthcare system where the data used to help a patient today will benefit those of tomorrow.”

In total ten Swiss companies were among the Tech Tour Growth 50. These include: Acronis (SaaS), Ava (Health), Beqom (Saas), Chronext (E-commerce), Coople (SaaS), Flyability (Hardware/Drones), Nexthink (SaaS), Scandit (IoT) and GetYourGuide (E-commerce).

Falk Müller-Veerse, Partner, Bryan, Garnier & Co, and Chairman of the 2019 Selection Committee, added “Europe is coming into its own with regard to the number of world class growth companies it is able to nurture, and the quality of teams in these companies is increasingly world class. As a single reference point, there were 70 unicorns in Europe in 2017 versus just 1 in 2005. The future outlook is promising.  As entrepreneurship becomes increasingly mainstream, there is a growing pool of high potential start-ups from which future leaders will emerge. In 2019 our selection team, comprising a sizeable group of the most active venture capitalists in Europe, has once again carefully picked the most promising European company from the 50 that met our multi-variable criteria of scale, growth and success.”

(Press release)
Picture: TechTour

0Comments

More news about

Sophia Genetics SA

Company profiles on startup.ch

Sophia Genetics SA

rss